CD38-targeted ImmunoPET
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD38-targeted ImmunoPET, covering 2023-06-27 to 2023-06-27. Get the full timeline:
Most recent: Clinical Trial Update: A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma [Phase 2]